Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LAM launches wound gel in Latin America:

This article was originally published in Clinica

Executive Summary

Transdermal drug delivery systems specialist LAM Pharmaceutical today announced the launch of its IPM Wound Gel. Distributors and healthcare professionals from Argentina, Brazil, Costa Rica, Ecuador, El Salvador and Panama have expressed an interest in the gel, claims the Lewiston, New York-based company. It features LAM's Ionic Polymer Matrix (IPM) technology - "a combination of electrically charged and non-charged molecules with wound-healing properties". LAM has offices in Canada (Toronto) and China (Beijing).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel